Filing Details
- Accession Number:
- 0001363585-12-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-27 16:09:37
- Reporting Period:
- 2012-06-25
- Filing Date:
- 2012-06-27
- Accepted Time:
- 2012-06-27 16:09:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1059784 | Generex Biotechnology Corp | GNBT | Pharmaceutical Preparations (2834) | 820490211 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363585 | Stephen Fellows | 33 Harbour Square Suite 202 Toronto A6 M5J 2G2 | Acting Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-06-25 | 546,448 | $0.09 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares sold were acquired by the reporting person on June 21, 2012 upon exercise of options to purchase 546,448 shares of the issuer's common stock, which were granted by the Board of Directors on June 6, 2012 in lieu of cash payment of deferred compensation. The option grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 20, 2012 and was made pursuant to the terms of the issuer's 2006 stock plan.
Billionaire Hedge Funds
